Aug 01, 2021
Volume 39Issue 8p745-852, e1-e2
Special Issue: Microphysiological Systems
Recent advances in 3D in vitro models have created a multitude of novel possibilities to study inter-organ communications
and complex pathophysiologies. The cover image illustrates the gut microbiota and
kidney, whose bidirectional crosstalk is involved in the development and progression
of diseases such as chronic kidney disease. In pages 811–823 of this issue, Giordano
and colleagues discuss how the efficacy of microphysiological systems in mimicking
the mechanisms operating in vivo and enabling organ interconnections, combined with their ability to control for individual
experimental parameters, are making these systems a valuable breakthrough for biomedical
applications in the pharmaceutical industry. Background image: human colon organoid
on a hollow fi ber membrane chip system (DAPI, blue; ZO-1, green). Cover image created
by Laura Giordano and Silvia Mihaila....Show more
Recent advances in 3D in vitro models have created a multitude of novel possibilities to study inter-organ communications
and complex pathophysiologies. The cover image illustrates the gut microbiota and
kidney, whose bidirectional crosstalk is involved in the development and progression
of diseases such as chronic kidney disease. In pages 811–823 of this issue, Giordano
and colleagues discuss how the efficacy of microphysiological systems in mimicking
the mechanisms operating in vivo and enabling organ interconnections, combined with their ability to control for individual
experimental parameters, are making these systems a valuable breakthrough for biomedical
applications in the pharmaceutical industry. Background image: human colon organoid
on a hollow fi ber membrane chip system (DAPI, blue; ZO-1, green). Cover image created
by Laura Giordano and Silvia Mihaila.